Bloomage Biotechnology Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 1,483

Employees

  • Stock Symbol
  • 688363

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $8.48
  • (As of Thursday Closing)

Bloomage Biotechnology General Information

Description

Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Corporate Office
  • Tower D, Bloomage International Center
  • Floor 33, 6A, Jianguomenwai Avenue
  • Beijing
  • China
+86 010 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bloomage Biotechnology Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.48 $8.52 $7.04 - $18.74 $4.09B 482M 2.31M $0.24

Bloomage Biotechnology Financials Summary

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 5,570,503 9,135,077 11,464,814 10,482,652
Revenue 887,525 944,265 766,256 381,080
EBITDA 128,134 196,853 159,699 117,399
Net Income 114,534 144,170 121,159 93,483
Total Assets 1,144,372 1,258,353 1,177,223 885,030
Total Debt 27,247 56,497 47,068 13,676
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bloomage Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bloomage Biotechnology‘s full profile, request access.

Request a free trial

Bloomage Biotechnology Executive Team (5)

Name Title Board Seat Contact Info
Jin Xuekun Chief Executive Officer
Gong AnMin Executive Director & Member of the Nomination Committee
Zhao Yan Chairman & Executive Director
You’re viewing 3 of 5 executive team members. Get the full list »

Bloomage Biotechnology Board Members (7)

Name Representing Role Since
00000 000 Bloomage Biotechnology Board Member 000 0000
00 0000000 Bloomage Biotechnology Board Member 000 0000
0000 0000 Bloomage Biotechnology Board Member 000 0000
0000 000 Bloomage Biotechnology Chairman & Executive Director 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Bloomage Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bloomage Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bloomage Biotechnology‘s full profile, request access.

Request a free trial

Bloomage Biotechnology Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hefei HRG Longyan Intelligent Equipment 26-Oct-2022 00000 0000 00.000 Paper Containers and Packaging
Peptites Biotech 29-Jun-2022 00000 0000 000.00 Biotechnology
Revitacare 08-Jan-2017 0000000000 000.00 Other Devices and Supplies
Laboratoires Vivacy 22-Dec-2016 000000000 Medical Supplies
Medybloom 27-Jul-2015 Joint Venture Pharmaceuticals
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Bloomage Biotechnology Subsidiaries (1)

Company Name Industry Location Founded
Revitacare Other Devices and Supplies Paris, France 0000
To view Bloomage Biotechnology’s complete subsidiaries history, request access »

Bloomage Biotechnology ESG

Risk Overview

Risk Rating

Updated January, 18, 2023

42.04 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,605

Rank

00.00

Percentile

Chemicals

Industry

00 of 575

Rank

00.00

Percentile

Specialty Chemicals

Subindustry

00 of 147

Rank

00.00

Percentile

To view Bloomage Biotechnology’s complete esg history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »